Logo image of KG

KESTREL GROUP (KG) Stock Fundamental Analysis

USA - NASDAQ:KG - BMG5260K1027 - Common Stock

22.71 USD
+2.87 (+14.47%)
Last: 11/3/2025, 8:05:13 PM
Fundamental Rating

0

Taking everything into account, KG scores 0 out of 10 in our fundamental rating. KG was compared to 146 industry peers in the Insurance industry. KG may be in some trouble as it scores bad on both profitability and health. KG does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

KG had negative earnings in the past year.
KG had a negative operating cash flow in the past year.
In multiple years KG reported negative net income over the last 5 years.
In the past 5 years KG always reported negative operating cash flow.
KG Yearly Net Income VS EBIT VS OCF VS FCFKG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M -1B

1.2 Ratios

KG's Return On Assets of -11.31% is on the low side compared to the rest of the industry. KG is outperformed by 94.52% of its industry peers.
With a Return On Equity value of -87.40%, KG is not doing good in the industry: 93.84% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -11.31%
ROE -87.4%
ROIC N/A
ROA(3y)-4.94%
ROA(5y)-1.43%
ROE(3y)-146.93%
ROE(5y)-79.11%
ROIC(3y)N/A
ROIC(5y)N/A
KG Yearly ROA, ROE, ROICKG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300 -400

1.3 Margins

KG does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
KG Yearly Profit, Operating, Gross MarginsKG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 -200 -300

0

2. Health

2.1 Basic Checks

KG has less shares outstanding than it did 1 year ago.
KG has more shares outstanding than it did 5 years ago.
The debt/assets ratio for KG is higher compared to a year ago.
KG Yearly Shares OutstandingKG Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M 5M
KG Yearly Total Debt VS Total AssetsKG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

KG has a Debt/Equity ratio of 1.16. This is a high value indicating a heavy dependency on external financing.
KG has a worse Debt to Equity ratio (1.16) than 89.73% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.16
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACCN/A
KG Yearly LT Debt VS Equity VS FCFKG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B -1B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
KG Yearly Current Assets VS Current LiabilitesKG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

0

3. Growth

3.1 Past

The earnings per share for KG have decreased strongly by -290.26% in the last year.
The Revenue for KG has decreased by -61.65% in the past year. This is quite bad
KG shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -37.29% yearly.
EPS 1Y (TTM)-290.26%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%857.79%
Revenue 1Y (TTM)-61.65%
Revenue growth 3Y-17.22%
Revenue growth 5Y-37.29%
Sales Q2Q%-78.25%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
KG Yearly Revenue VS EstimatesKG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B
KG Yearly EPS VS EstimatesKG Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 0 20 -20 -40 -60 -80 -100

0

4. Valuation

4.1 Price/Earnings Ratio

KG reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
KG Price Earnings VS Forward Price EarningsKG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
KG Per share dataKG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 -20

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for KG!.
Industry RankSector Rank
Dividend Yield N/A

KESTREL GROUP

NASDAQ:KG (11/3/2025, 8:05:13 PM)

22.71

+2.87 (+14.47%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)08-15 2025-08-15
Earnings (Next)11-10 2025-11-10
Inst Owners182.52%
Inst Owner Change-1.14%
Ins Owners134.37%
Ins Owner Change9.69%
Market Cap175.78M
Revenue(TTM)31.73M
Net Income(TTM)-131175000
Analysts40
Price TargetN/A
Short Float %N/A
Short Ratio4.27
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 5.54
P/FCF N/A
P/OCF N/A
P/B 1.17
P/tB 1.27
EV/EBITDA N/A
EPS(TTM)-25.41
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-9.41
FCFYN/A
OCF(TTM)-9.41
OCFYN/A
SpS4.1
BVpS19.39
TBVpS17.91
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -11.31%
ROE -87.4%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-4.94%
ROA(5y)-1.43%
ROE(3y)-146.93%
ROE(5y)-79.11%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.03
Health
Industry RankSector Rank
Debt/Equity 1.16
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score2
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-290.26%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%857.79%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-61.65%
Revenue growth 3Y-17.22%
Revenue growth 5Y-37.29%
Sales Q2Q%-78.25%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-417.89%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y57.35%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y57.35%
OCF growth 3YN/A
OCF growth 5YN/A

KESTREL GROUP / KG FAQ

What is the ChartMill fundamental rating of KESTREL GROUP (KG) stock?

ChartMill assigns a fundamental rating of 0 / 10 to KG.


Can you provide the valuation status for KESTREL GROUP?

ChartMill assigns a valuation rating of 0 / 10 to KESTREL GROUP (KG). This can be considered as Overvalued.


What is the profitability of KG stock?

KESTREL GROUP (KG) has a profitability rating of 0 / 10.


Can you provide the financial health for KG stock?

The financial health rating of KESTREL GROUP (KG) is 0 / 10.